Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
White Mountains Insurance
WTM
$5.13B
| $5.99M | ﹤0.01% |
5,601
+352
| +7% | +$393K |
|
1452
Euronet Worldwide
EEFT
$2.7B
| $5.98M | ﹤0.01% |
46,952
+7,497
| +19% | +$994K |
|
|
FMBI
1453
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $5.97M | ﹤0.01% |
314,016
-16,959
| -5% | -$312K |
|
|
HOUS
1454
DELISTED
Anywhere Real Estate
HOUS
| $5.96M | ﹤0.01% |
339,918
-46,635
| -12% | -$822K |
|
1455
Ultragenyx Pharmaceutical
RARE
$2.55B
| $5.93M | ﹤0.01% |
65,751
+16,133
| +33% | +$1.46M |
|
|
CSII
1456
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.92M | ﹤0.01% |
180,426
+20,538
| +13% | +$766K |
|
1457
Cinemark Holdings
CNK
$4.32B
| $5.89M | ﹤0.01% |
306,769
+99,911
| +48% | +$1.7M |
|
|
AIV
1458
Aimco
AIV
$383M
| $5.87M | ﹤0.01% |
856,587
-78,210
| -8% | -$538K |
|
|
TWO
1459
Two Harbors Investment
TWO
$1.27B
| $5.86M | ﹤0.01% |
231,161
+13,617
| +6% | +$357K |
|
1460
Hancock Whitney
HWC
$6.24B
| $5.86M | ﹤0.01% |
124,368
-12,250
| -9% | -$543K |
|
|
UNVR
1461
DELISTED
Univar Solutions Inc.
UNVR
| $5.86M | ﹤0.01% |
245,999
-41,089
| -14% | -$971K |
|
1462
InterDigital
IDCC
$8.89B
| $5.86M | ﹤0.01% |
86,375
+6,064
| +8% | +$420K |
|
|
CPE
1463
DELISTED
Callon Petroleum Company
CPE
| $5.84M | ﹤0.01% |
119,112
-19,123
| -14% | -$740K |
|
1464
Piper Sandler
PIPR
$5.29B
| $5.84M | ﹤0.01% |
168,752
+13,644
| +9% | +$457K |
|
|
TSE
1465
DELISTED
Trinseo
TSE
| $5.84M | ﹤0.01% |
108,120
-6,552
| -6% | -$341K |
|
1466
Cavco Industries
CVCO
$4.55B
| $5.83M | ﹤0.01% |
24,627
+1,698
| +7% | +$408K |
|
1467
TETRA Technologies
TTI
$1.26B
| $5.82M | ﹤0.01% |
1,865,324
+297,079
| +19% | +$953K |
|
1468
Twist Bioscience
TWST
$7.25B
| $5.8M | ﹤0.01% |
54,243
+22,992
| +74% | +$2.63M |
|
1469
Murphy Oil
MUR
$4.78B
| $5.77M | ﹤0.01% |
230,955
-99,370
| -30% | -$2.14M |
|
1470
Cannae Holdings
CNNE
$649M
| $5.75M | ﹤0.01% |
184,845
+16,090
| +10% | +$518K |
|
1471
Hilltop Holdings
HTH
$2.24B
| $5.75M | ﹤0.01% |
175,895
+7,999
| +5% | +$265K |
|
1472
Innospec
IOSP
$2.28B
| $5.74M | ﹤0.01% |
68,156
+5,010
| +8% | +$447K |
|
1473
Madison Square Garden
MSGS
$9.39B
| $5.73M | ﹤0.01% |
30,804
+730
| +2% | +$125K |
|
|
PMT
1474
PennyMac Mortgage Investment
PMT
$842M
| $5.72M | ﹤0.01% |
290,297
-8,217
| -3% | -$161K |
|
1475
Corcept Therapeutics
CORT
$12B
| $5.71M | ﹤0.01% |
290,211
+21,107
| +8% | +$442K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.